Skip to main content
Equibles

Parallel Advisors, LLC

Position in ABBV — AbbVie Inc.

CIK 1690010 SAN FRANCISCO, CA
Back to ABBV Full portfolio

Position in ABBV

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$25,376,887
+$2,785,114 QoQ
Shares Held
100,846
-2.9% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
#538
of 4,176 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Parallel Advisors, LLC holds $119,634,223 across 18 Drug Manufacturers - General names. ABBV ranks #2 (21.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 31,933 $38,301,401
2 ABBV
AbbVie Inc.
This page 		100,846 $25,376,887
3 JNJ
Johnson & Johnson
 83,035 $21,088,398
4 GILD
Gilead Sciences, Inc.
 76,862 $9,710,745
5 MRK
Merck & Co., Inc.
 66,774 $8,580,459
6 AMGN
Amgen Inc
 11,139 $4,033,654
7 NVO
Novo Nordisk A S
 56,877 $2,726,683
8 NVS
Novartis AG
 15,640 $2,451,100

All Filings in ABBV

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $25,376,887 100,846
2026-03-31 $22,591,773 103,875
2025-12-31 $23,439,646 102,585
2025-09-30 $24,361,018 105,213
2025-06-30 $19,418,450 104,614
2025-03-31 $22,427,439 107,042
2024-12-31 $19,224,474 108,185
2024-09-30 $21,486,811 108,805
2024-06-30 $18,885,552 110,107
2024-03-31 $20,294,498 111,447
2023-12-31 $17,109,307 110,404
2023-09-30 $16,718,420 112,159
2023-06-30 $14,887,665 110,500
2023-03-31 $17,819,956 111,815
2022-12-31 $5,931,733 36,704
2022-09-30 $4,482,211 33,397
2022-06-30 $4,726,517 30,860
2022-03-31 $5,070,800 31,280
2021-12-31 $4,278,910 31,602
2021-09-30 $3,056,927 28,339
2021-06-30 $3,171,041 28,152
2021-03-31 $2,707,123 25,015
2020-12-31 $2,542,455 23,728
2020-09-30 $2,214,012 25,277
2020-06-30 $2,402,660 24,472
2020-03-31 $1,725,322 22,645